Current relevance of pharmaceutical economy
Keywords:
Emerging Markets, Developed Markets, Pharmaceutical Companies, Drugs and Disease, BRICS, MISTAbstract
Emerging markets represent an exceptional opportunity for the
pharmaceutical industry. Although a precise definition is not yet available,
economists define emerging markets as developing prosperous countries in which
investment is expected to result in higher income despite high risks. Qualifying a
market as emerging is not merely based on the economic status of the country, but
also on several criteria that render the definition applicable to each country.
References
Grabowski H. The changing economics of pharmaceutical research and
development. In this volume . Washington, D.C. : National Academy Press, 1991.
Teitelman R, Siwolop S, Baldo A. Global report on pharmaceuticals. Financial
World 1989 ; 158: 53-80.
Pharmaceutical Manufacturers Association. PMA Statistical Fact Book.
Washington, D.C. : Pharmaceutical Manufacturers Association, 1989.
Pharmaceutical Manufacturers Association. 1989 Annual Report. Washington,
DC : Pharmaceutical Manufacturers Association, 1989.
Merck & Co., Inc. 1989 Annual Report. Rahway : Merck & Co., Inc., 1990.
Veverka MJ. Pharmaceuticals. New York, Booz Allen & Hamilton, 1989.
Patent Departments, Merck & Co., Inc. , and Hoffman-La Roche. Unpublished
study of 77 human and animal health products approved from September 1984
through 1989
